{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:22:32Z","timestamp":1788877352505,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tice.2025.102902","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T14:01:06Z","timestamp":1743602466000},"page":"102902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["METTL3-mediated m6A modification of MT1G inhibits papillary thyroid carcinoma cell growth and metastasis via Wnt\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"95","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2025.102902_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MED.0000000000000559","article-title":"Contemporary evaluation and management of tall cell variant of papillary thyroid carcinoma","volume":"27","author":"Cartwright","year":"2020","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.tice.2025.102902_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2025.102902_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jso.21804","article-title":"Thyroid cancer and lymph node metastases","volume":"103","author":"Clark","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.tice.2025.102902_bib4","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","article-title":"Papillary thyroid cancer-aggressive variants and impact on management: a narrative review","volume":"37","author":"Coca-Pelaz","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.tice.2025.102902_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/0145561320982695","article-title":"Incidental papillary thyroid cancer identified during parathyroidectomy","volume":"101","author":"Crenshaw","year":"2022","journal-title":"Ear Nose Throat"},{"key":"10.1016\/j.tice.2025.102902_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/labinvest.2008.17","article-title":"Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma","volume":"88","author":"Ferrario","year":"2008","journal-title":"Lab. Invest"},{"key":"10.1016\/j.tice.2025.102902_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112249","article-title":"SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt\/beta-catenin signaling","volume":"396","author":"Geng","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tice.2025.102902_bib8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","article-title":"METTL3 restrains papillary thyroid cancer progression via m(6)A\/c-Rel\/IL-8-mediated neutrophil infiltration","volume":"29","author":"He","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tice.2025.102902_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevImmunol.2023050267","article-title":"m6A Writer METTL3-Mediated lncRNA LINC01125 prevents the malignancy of papillary thyroid cancer","volume":"43","author":"He","year":"2023","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.tice.2025.102902_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2020.102547","article-title":"m(6)A RNA methylation regulators have prognostic value in papillary thyroid carcinoma","volume":"41","author":"Hou","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.tice.2025.102902_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ijc.11006","article-title":"Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma","volume":"104","author":"Huang","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tice.2025.102902_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","article-title":"METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tice.2025.102902_bib13","first-page":"93","article-title":"Metallothionein--a promising tool for cancer diagnostics","volume":"110","author":"Krizkova","year":"2009","journal-title":"Bratisl. Med. J."},{"key":"10.1016\/j.tice.2025.102902_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-0716-2505-7_7","article-title":"Histopathological assessment for papillary thyroid carcinoma","volume":"2534","author":"Lam","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tice.2025.102902_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fbioe.2018.00089","article-title":"Link between m6A modification and cancers","volume":"6","author":"Liu","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tice.2025.102902_bib16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","article-title":"METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2025.102902_bib17","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1038\/s41467-022-34209-5","article-title":"METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2025.102902_bib18","first-page":"2144","article-title":"Micro-RNAs signatures in papillary thyroid carcinoma","volume":"25","author":"Mastronikolis","year":"2020","journal-title":"J. Buon."},{"key":"10.1016\/j.tice.2025.102902_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1210\/er.2019-00085","article-title":"Contemporary debates in adult papillary thyroid cancer management","volume":"40","author":"McLeod","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tice.2025.102902_bib20","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4103\/jcrt.JCRT_1268_20","article-title":"Assessment of preoperative thyroglobulin levels in papillary thyroid cancer","volume":"18","author":"Melik","year":"2022","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.tice.2025.102902_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jss.2022.01.019","article-title":"Low-risk papillary thyroid cancer: treatment de-escalation and cost implications","volume":"275","author":"Paluskievicz","year":"2022","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.tice.2025.102902_bib22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/thy.2021.0033","article-title":"Thyrotropin suppression for papillary thyroid cancer: a physician survey study","volume":"31","author":"Papaleontiou","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.tice.2025.102902_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.881447","article-title":"Ferroptosis-related gene MT1G as a novel biomarker correlated with prognosis and immune infiltration in colorectal cancer","volume":"10","author":"Peng","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tice.2025.102902_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tice.2025.102902_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/clinem\/dgab917","article-title":"Nonsurgical management of thyroid nodules: the role of ablative therapies","volume":"107","author":"Stan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tice.2025.102902_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41389-019-0176-5","article-title":"MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53","volume":"8","author":"Wang","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.tice.2025.102902_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature18298","article-title":"Corrigendum: structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex","volume":"534","author":"Wang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tice.2025.102902_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106244","article-title":"Epigenetic regulation of the DNMT1\/MT1G\/KLF4\/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma","volume":"180","author":"Wei","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tice.2025.102902_bib29","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41556-022-00968-y","article-title":"METTL3 preferentially enhances non-m(6)A translation of epigenetic factors and promotes tumourigenesis","volume":"24","author":"Wei","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tice.2025.102902_bib30","first-page":"5179","article-title":"Metallothionein isoform expression in benign and malignant thyroid lesions","volume":"37","author":"Wojtczak","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.tice.2025.102902_bib31","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2021-0067","article-title":"MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K\/AKT signaling pathway","volume":"45","author":"Xu","year":"2022","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.tice.2025.102902_bib32","doi-asserted-by":"crossref","first-page":"1140888","DOI":"10.3389\/fendo.2023.1140888","article-title":"Establishment of papillary thyroid cancer organoid lines from clinical specimens","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tice.2025.102902_bib33","doi-asserted-by":"crossref","first-page":"1340153","DOI":"10.1155\/2020\/1340153","article-title":"Herbal active ingredients: an emerging potential for the prevention and treatment of papillary thyroid carcinoma","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tice.2025.102902_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","article-title":"Roles of METTL3 in cancer: mechanisms and therapeutic targeting","volume":"13","author":"Zeng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tice.2025.102902_bib35","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1002\/jcp.30828","article-title":"N6-methyladenosine (m6A) modification in gynecological malignancies","volume":"237","author":"Zhang","year":"2022","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.tice.2025.102902_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101739","article-title":"KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt\/beta-catenin pathway","volume":"75","author":"Zhong","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.tice.2025.102902_bib37","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11010-023-04841-w","article-title":"RNA m6A methylation regulators in sepsis","volume":"479","author":"Zhu","year":"2023","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.tice.2025.102902_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41419-022-04817-6","article-title":"METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662500182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662500182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:28:10Z","timestamp":1750260490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004081662500182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S004081662500182X"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.102902","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3-mediated m6A modification of MT1G inhibits papillary thyroid carcinoma cell growth and metastasis via Wnt\/\u03b2-catenin pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.102902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102902"}}